Bill Snyder

September 21, 2017

University of Kansas honors Lindsley’s pharmacology research

Craig Lindsley, Ph.D., co-director of the Vanderbilt Center for Neuroscience Drug Discovery, has been honored by the University of Kansas with the 2018 Edward E. Smissman Lectureship for his outstanding contributions to the fields of medicinal chemistry and molecular pharmacology.

By Bill Snyder
September 21, 2017

Global Health at Vanderbilt forum set for Sept. 25

Kayvon Modjarrad, M.D., Ph.D., director of Emerging Infectious Disease Threats at the Walter Reed Army Institute of Research in Silver Spring, Maryland, will be the keynote speaker Sept. 25 at a forum entitled “Global Health at Vanderbilt.”

By Bill Snyder
nurse marking chart in intensive care unit
September 19, 2017

Medication safety in the ICU

Facilitated reporting of medication-related events in the intensive care unit can provide opportunities for optimizing quality of care and patient safety.

By Bill Snyder
September 7, 2017

Combination therapy PrEP offers effective way to prevent HIV infection

Rates of new HIV infections in the United States are declining — except among men who have sex with men. Rates are particularly high among African-American and Hispanic men and especially in the South.

By Bill Snyder
September 7, 2017

Journey of discovery starts from Simple Beginnings

Vanderbilt University welcomed 104 new doctoral students Sept. 1 during the eighth annual Simple Beginnings ceremony in a Light Hall lecture room filled with family members and other well-wishers.

By Bill Snyder
August 31, 2017

Program for scientists to move discoveries into clinical practice

Vanderbilt University Medical Center (VUMC) has established a new career development program for scientists in implementation research. The goal is to speed the uptake and translation of scientific discoveries into routine clinical practice.

By Bill Snyder
August 31, 2017

Epigenetics expert Allis set for Sept. 7 Discovery Lecture

Internationally known epigeneticist C. David Allis, Ph.D., will deliver the first Flexner Discovery Lecture of the academic year at 4 p.m. Thursday, Sept. 7, in room 208 Light Hall.
By Bill Snyder
August 24, 2017

Drug discovery efforts may lead to new Rett syndrome treatments

Vanderbilt University research-ers have relieved symptoms of Rett syndrome in a mouse model with a small molecule that works like the dimmer switch in an electrical circuit.
By Bill Snyder
August 17, 2017

Wilkins named to national committee exploring return of research results

Consuelo Wilkins, M.D., MSCI, executive director of the Meharry-Vanderbilt Alliance, has been appointed to a national committee charged with determining how best to return to research participants the results of studies of their blood and other bio-specimens.
By Bill Snyder
August 9, 2017

Breast Cancer Genomic Profiling Reveals Clues to Treatment Resistance

Thanks to advances in treatment, the relative five-year survival rate from all combined subtypes of breast cancer now exceeds 90 percent and yet the disease remains the third leading cause of cancer deaths in the United States after lung and colorectal cancers.
By Bill Snyder
August 9, 2017

Stress may switch on bone “mets”

New findings could explain the link between chronic stress and reduced survival in women diagnosed with breast cancer, and could lead to new strategies to improve treatment outcomes.
By Bill Snyder
August 7, 2017

Vanderbilt begins Phase 1 trials of new Alzheimer’s drug

Developed at Vanderbilt, VU319 is designed to precisely target a specific neuron receptor associated with cognitive function while avoiding potentially dangerous side effects.
By Bill Snyder
1 … 60 61 62 63 64 … 110